DB
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis | Science advances | 2022 | 206 | 107 | |||
MHC class II antigen presentation by lymphatic endothelial cells in tumors promotes intratumoral regulatory T cell-suppressive functions | Cancer Immunology Research | 2021 | 270 | 7 | |||
Macroautophagy in lymphatic endothelial cells inhibits T cell-mediated autoimmunity | Journal of Experimental Medicine | 2021 | 249 | 166 | |||
Intratumoral CpG-B Promotes Antitumoral Neutrophil, cDC, and T-cell Cooperation without Reprograming Tolerogenic pDC | Cancer Research | 2018 | 373 | 3 | |||
Absence of MHC-II expression by lymph node stromal cells results in autoimmunity | Life Science Alliance | 2018 | 322 | 150 | |||
IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity | Journal of autoimmunity | 2016 | 576 | 172 | |||
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation | Journal of autoimmunity | 2016 | 588 | 259 | |||
Ag-Presenting CpG-Activated pDCs Prime Th17 Cells That Induce Tumor Regression | Cancer research | 2014 | 669 | 265 | |||
Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4⁺ T cell tolerance | The Journal of experimental medicine | 2014 | 684 | 352 |